study the additional effect of snuhi tail with daflon in woman with varicose vein

study the add on effect of snuhi taila with diosmin and hesperidin in managment of vericose vein in parous woman - STD

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027586

Enrollment

200

Registered

2020-09-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I831- Varicose veins of lower extremities with inflammation

Interventions

Intervention1: Local application of snuhi taila with oral administration of diosmin and hesperidin: Tab. Daflon 500mg bd with local application of snuhi taila.Oberservation will be recorded on every f

Eligibility

Inclusion criteria

Inclusion criteria: 1 parous women having sign and symtoms of unilateral or bilateral lower limb vericose vein upto clas two [spidervein and vericose vein] of venous disorder 2 patient willing for experimental/trail group and control group 3 patient of age group 30 to 70 years

Exclusion criteria

Exclusion criteria: 1 Anemicpatient with HB less than 8 gram % 2 thrombophlebitis 3 malnourish patient[ as per age height and weight proportion] 4 bleeding disorder[increased B T and C T 5 patient recieving drug like asprine 6 congenital venous insufficiency

Design outcomes

Primary

Measure	Time frame
Additional effect of snuhi tail with diosmin and hisperidinTimepoint: every 15 days for 3 months	—

Secondary

Measure	Time frame
Established Local Application of Snuhi Tail in Management of Vericose VeinTimepoint: 3 years	—

Countries

India

Contacts

Public ContactKanchan SHekokar

Government Ayurved College Nanded

ukhalkarvp@yahoo.com7755921987

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026